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ABSTRACT OF THE THESIS 
 
A Qualitative Study of Psychosocial Needs for Individuals with Lung Cancer 
 
by 
Kevin R. Criswell 
Doctor of Philosophy, Graduate Program in Biochemistry 
Loma Linda University, August 2012 
Dr. Jason E. Owen, Chairperson 
 
Lung cancer affects many people in the United States, accounting for 14.5% of 
cancer cases in 2010.  Additionally, it is responsible for more cancer-related deaths than 
any other cancer type.  Those living with lung cancer also experience a higher prevalence 
of psychological distress and mood problems relative to most other cancer types.  Despite 
the high physical and mental health burden borne by those living with lung cancer, 
psychosocial research on lung cancer generally lags far behind comparable studies in 
other cancer populations. Evidence from the few interventions developed specifically for 
lung cancer patients demonstrate an underutilization of those services, which is inferred 
from generally low response rates from eligible participants. Although a low participation 
rate may demonstrate the need to investigate the barriers of participating in interventions, 
little research on that topic is currently available.  Also, it is not clear what factors predict 
refusal to participate in psychosocial interventions for the lung cancer population, despite 
the available data on demographic and medical differences between eligible those who 
did and those who did not participate.  Overall, there is limited evidence available for 
preferred interventions, for favored methods of receiving interventions (e.g., Internet, 
 xiii 
face-to-face, telephone), and for perceived barriers to access and maintain engagement in 
available psychosocial interventions for lung cancer patients.   
A qualitative study that utilizes a grounded theory approach to the analysis of 
interview data from lung cancer patients can address the current gap in understanding of 
lung cancer patients’ perspective on three specific areas: 1) the most important 
psychosocial needs to address and what factors contribute to higher importance, 2) 
interest in different psychosocial services and what factors contribute to low and high 
interest, and 3) what factors serve as barriers to engage in psychosocial interventions.  
Elucidating these three areas will increase researchers’ understanding of lung cancer 
patients’ perspectives via the development of a grounded theory, which investigators can 
utilize to better address the psychosocial and quality of life needs of this cancer 
population. 
 
 1 
CHAPTER ONE 
BACKGROUND AND SIGNIFICANCE 
 
 
Lung Cancer 
Lung cancer is projected to be the most diagnosed cancer at 222,520 new cases in 
the USA in 2010 (American Cancer Society [ACS], 2010).  Responsible for an estimated 
157,300 deaths in the U.S. in 2010, lung cancer has the highest mortality of any cancer 
type (ACS, 2010).  Out of 789,620 new cancer diagnoses for males and 739,940 for 
females, cancer of the lung is estimated to be the second-most diagnosed cancer in men 
(15%) and women (14%) in 2010 behind prostate (28%) and breast cancers (28%), 
respectively (ACS, 2010).   
Lung cancer can be separated into two major categories: non-small cell lung 
cancer (NSCLC) and small cell lung cancer (SCLC).  NSCLC and SCLC are different in 
their prevalence and mortality rate.  NSCLC is more commonly diagnosed (85%) than 
small cell lung cancer (14%) (ACS, 2010; combined percentage 99% due to rounding).  
The five-year survival rate for patients with NSCLC (17%) is higher than patients 
diagnosed with SCLC (6%). 
Unfortunately, the five-year survival rate for lung cancer has remained at the 
same low level from 1975 to 1986 (13%) with a slight increase between 1999 and 2005 
(16%).  This increase in survival is likely related to a combination of factors, which 
include a decrease in overall smoking rates in the past 40 years and improved techniques 
(e.g., spiral computed tomography scanning) for detecting lung cancer in early stages 
within high-risk populations.  However, it has been noted that evidence for the 
contribution of advances in early detection techniques is still being collected and has not 
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yet been proven to reduce mortality in lung cancer (ACS, 2010).  When compared to the 
national average across cancer types in 1999-2005 (68%), the five-year survival rate for 
lung cancer is much lower.  This difference can be attributed to a combination of factors 
related to lung cancer diagnoses that are typically made at a late stage of the disease, 
which can be due to such factors as ambiguous symptoms (e.g., an unusual cough) and 
aspects related to lung cancer screening (e.g., not wanting a bronchoscopy; ACS, 2010; 
Yardley, Davis, & Sheldon, 2001).  Generally, a later stage of cancer implies that the 
cancer has spread beyond the initial cancer site to the surrounding tissues or lymph 
glands (regional stage) or metastasized to separate organs (distant stage).  As the cancer 
progresses to later stages, it becomes increasingly difficult to effectively neutralize the 
cancer cells.  Because only 15% of lung cancer cases are initially diagnosed at a local 
stage (ACS, 2010), it is logical that the survival rate is low. 
 
Risk Factors 
Cigarette smoking has been determined to be the most salient risk factor for 
contracting lung cancer.  It has been demonstrated that the relative risk of developing 
lung cancer increases with the duration and amount of the smoking.  Although other 
airborne substances (e.g., secondhand smoke, asbestos, talcum powder, and pollution) 
have been found to contribute to the development of lung cancer, smoking cigarettes has 
received the most attention from healthcare professionals and the public (American 
Cancer Society [ACS], 2010).  In their lifetimes, about 17.2 % of male and 11.6% of 
female smokers (14.4%, combined) will develop lung cancer, and smoking behavior has 
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been found to be attributable to about 90% of lung cancer cases (Alberg & Samet, 2003; 
Villeneuve & Mao, 1994). 
 
Psychosocial Issues in Lung Cancer 
Several reviews have identified areas of psychosocial need in lung cancer, which 
include quality of life, depression, distress, and smoking cessation.  In addition to those 
psychosocial issues, the constructs of stigma, self-blame, and guilt are gaining increasing 
attention in the literature (Bedor, Alexander, & Edelman, 2005; Carlsen, Jensen, 
Jacobsen, Krasnik, & Johansen, 2005; Joyce, Schwartz, & Huhmann, 2008).  Although 
stigma has been documented across cancer types, it seems lung cancer patients 
experience more perceived cancer-related stigma relative to breast and prostate cancer 
patients (Loconte, Else-quest, Eickhoff, Hyde, & Schiller, 2008); stigma in lung cancer 
may also serve as a barrier to seeking care when symptoms of the disease are first 
detected by the patient (Chapple, Ziebland, & McPherson, 2004).  Self-blame and guilt 
were documented in the experiences of lung cancer patients, yet levels of these constructs 
seem to be explained more by a history of smoking than being diagnosed with a specific 
cancer type (LoConte et al., 2008).  However, levels of self-blame and guilt is likely to be 
high in lung cancer patients because about 90% of all lung cancer cases can be attributed 
to a history of smoking (American Cancer Society [ACS], 2010). 
When compared to other cancer types, lung cancer patients have experienced 
relatively greater levels of unmet need (Li & Girgis, 2006) and higher levels of 
psychological distress when compared to other cancer types (Zabora, Brintzenhofeszoc, 
Curbow, Hooker, & Piantadosi, 2001).  In an investigation using United States 
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population-based data, individuals diagnosed with lung cancer, female reproductive 
cancer, other, and multiple cancer diagnoses demonstrated the highest levels of distress, 
as measured by the Kessler-6 (Kaiser, Hartoonian, Owen, 2010).  In an investigation of 
significant independent correlates of high levels of supportive care needs in a sample of 
lung cancer patients, higher levels of need were associated with greater trauma, greater 
symptom burden, lower satisfaction with health care, and lower levels of physical 
functioning (Sanders, Bantum, Owen, Thornton, & Stanton, 2010).  As a subpopulation 
of cancer patients who demonstrate relatively high levels of poor psychosocial outcomes 
related and high levels of  unmet needs, it has been important to meet those needs with 
interventions that are tailored for lung cancer patients (Carlsen et al., 2005). 
This review of the current state of the literature on psychosocial needs and 
interventions for lung cancer patients will focus primarily on quality of life, distress, 
depression, anxiety, smoking, and the cluster of stigma, self-blame, and shame.  Since 
fatigue has also been identified as an important symptom with psychosocial implications, 
its prevalence will be provided as well.  First, the prevalence of each psychosocial issue 
will be presented, followed by theories utilized to guide studies in this area of the 
literature, the needs related to the psychosocial issues discussed, interventions 
implemented to address those needs in samples of lung cancer patients, and barriers to 
engage in available psychosocial interventions. 
 
Prevalence of Psychosocial Issues 
Generally, lung cancer patients and survivors have demonstrated high rates of 
clinically relevant psychosocial issues.  Unfortunately, the assessment of prevalence rates 
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in study samples is often hindered by the absence of clinical cutoffs for scales used.  
Characterizing psychosocial issues in lung cancer is further complicated by the utilization 
of different measurements of constructs and behaviors across studies. 
 
Quality of Life 
Quality of life (QoL) has been defined as a multidimensional construct, 
encompassing the physiological, psychological, and social wellbeing of a given 
individual (Fox & Lyon, 2006; Yang, 2009).  Examples of multidimensional scales used 
to measure quality of life in lung cancer studies include the European Organization for 
Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30; 
Bezjak et al., 2008) and the Functional Assessment of Cancer Therapy – General Version 
(FACT-G; LoRusso et al., 2003).  Both of these measures have lung cancer-specific 
modules, called the QLQ – Lung Cancer 13 (QLQ-LC13 and the FACT – Lung Version 
(FACT-L), that encompass the impact on QoL from symptoms and treatments that are 
typical for lung cancer patients (LoRusso et al., 2003).  These additional modules add a 
symptom and treatment burden component to the measurement of QoL that can provide a 
useful perspective in explaining how QoL is related to relevant study variables when 
sampling lung cancer patients.  It should be noted that these scales differ slightly in their 
assumption of the facets that compose QoL.  Specifically, the QLQ-C30 is designed to 
encompass five functional domain facets (i.e., Physical, Role, Social, Emotional, and 
Cognitive). The FACT-G has four factors of wellbeing (i.e., Emotional, Cognitive, 
Social, and Physical), which may be similar to the factors of the QLQ-C30.  However, it 
is unclear how these different scales differ with respect to convergent and divergent 
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validity with other psychosocial outcome measurements, and future studies are needed to 
determine whether these scales differ in their results across different subgroups of lung 
cancer patients (e.g., separated by lung cancer type and stage of cancer) and settings.   
Although QoL was defined as a multidimensional construct and measured using 
scales that encompass multiple facets of QoL, some studies used single-item measures of 
QoL (Gooneratne et al., 2007), possibly undermining the generalizability of their findings 
to other studies that implemented valid measures of the multidimensional construct of 
QoL.  It is certainly preferable to use a measure that reflects the multifaceted 
conceptualization of QoL along with items that are specific to the treatment because 
those measurements have been shown to be valid and reliable (Casañas i Comabella, 
Gibbons, & Fitzpatrick, 2010). 
Comparisons of QoL measures between studies are complex, given the different 
measurements of the construct used by different investigators.  For example, some studies 
have utilized measures that have been considered to be more general scales of overall 
well-being (e.g., QLQ-C30), whereas others have used scales more specific to lung 
cancer symptomology (e.g., LCSS).  Therefore, it is difficult to compare findings directly 
between studies of QoL in lung cancer patients. 
Also, the lack of generally accepted criteria for identifying low, moderate, and 
high levels of QoL in validated measures makes it difficult to determine rates of lung 
cancer patients who are considered to have a high or low level of QoL.  However, efforts 
(Slotman et al., 2009) were made to quantify levels of lowered QoL over time in SCLC 
patients (N = 188) who decreased at least 20 points (i.e., clinically relevant decrease) 
from baseline to three months (according to the QLQ-C30) across factors included in the 
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scale.  Rates of clinically relevant decreases in QoL subscales were as follows: 28.7% for 
global health status, 30.3% for role functioning, 16.5% for cognitive functioning, and 
17.0% for emotional functioning.  Future investigations should incorporate similar 
methods of quantifying clinically significant levels of QoL to aid reviews of the literature 
on overall wellbeing in lung cancer patients. 
Generally, longitudinal studies of QoL in lung cancer patients show decreases in 
the various domains of the underlying construct.  Although a small subsample of SCLC 
patients (n = 37) who received intravenous chemotherapy experienced a decline in role 
functioning over time (Naughton et al., 2002), this finding involved a small sample and is 
limited to a specific treatment and lung cancer type.  Future longitudinal investigations of 
QoL in lung cancer should involve large, nationally-representative samples to bolster the 
generalizability of results.  Although it is not clear as to exactly how great the level of 
need for QoL interventions is due to the lack of generally-accepted cutoff criteria for 
sequential levels of the multiple facets of overall wellbeing, the available literature does 
suggest that lung cancer patients who demonstrate a low performance status, dyspnea, 
and weight loss (Langendijk et al., 2000) will likely have a higher level of needs related 
to QoL issues. 
 
Distress 
Distress is understood to be a multidimensional construct that incorporates 
essentially any distressing area of a cancer patient’s life (Graves et al., 2007).  Distressing 
areas of the life may include physical health, effects of disease and treatment, and 
difficulty in social and emotional domains.  Interestingly, with such an encompassing 
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definition, measurements of distress have included combinations of depression and 
anxiety levels (Hospital Anxiety and Depression Scale), multiple domains of overall 
distress (Brief Symptom Inventory), and simple one-item Likert scale measures (Distress 
Thermometer) to assess the dynamic construct (Graves et al., 2007).   
Increases over time in rates of clinical distress have been found in samples of lung 
cancer patients.  In a sample of lung cancer patients, 29% (n = 52) at baseline, 33% (n = 
40) at three months, and 35% (n = 33) at six months were found to meet cutoff criteria for 
clinically significant levels of distress (Badr, Acitelli, & Taylor, 2008).  In a large sample 
of mixed cancer diagnoses (N = 4496), lung cancer patients (n = 629) achieved the 
highest rate of clinical distress (as measured by the Brief Symptom Inventory) compared 
to all other cancer types in the sample (43.4%; Zabora et al., 2001).  A larger rate of 
clinical distress (61.6%) was found in distress screening study of lung cancer patients (n 
= 333; Graves et al., 2007).  However, this study noted that 134 of the study sample had 
not received a definitive diagnosis of lung cancer, potentially undermining the results.  
Evidence has been found for increased severity of distress over time (Aubin et al., 2010), 
but small sample sizes limit the validity of this finding. 
 
Depression 
Some studies consider depression to be a multidimensional construct that is 
manifested through bidirectional interactions between biological, psychological, and 
social variables (i.e., the biopsychosocial model is inferred to conceptualize the role of 
depression; Lo et al., 2010).  Other studies have adhered closely to the conceptualization 
of depression set forth by the Diagnostic and Statistical Manual of Mental Disorders 
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(Spitzer, Williams, Gibbon, & First, 1990) third ed., revised criteria that was current at 
the time of the study (Nakaya et al., 2006; Uchitomi et al., 2003).  However, large 
discrepancies between rates of clinically significant depression have developed between 
using the Structured Clinical Interview and other validated measurements, such as the 
Center for Epidemiological Studies Depression Scale (CES-D), the Beck Depression 
Inventory (BDI) and the Hospital Anxiety and Depression Scale (HADS). 
Using the CES-D cutoff, 33-38.9% of lung cancer samples met the cutoff for a 
clinically significant level of depressive symptoms (Gonzalez & Jacobsen, 2010; 
Hopwood & Stephens, 2000; Kurtz, Kurtz, Stommel, Given, & Given, 2002).  A slightly 
lower rate of depression (28.6% of n = 119) was found in a sample of early-stage female 
NSCLC patients (Sarna et al., 2010).  Interestingly, a similar prevalence of severity of 
depressive symptoms (30%) has been found in a sample of spouses of lung cancer 
patients (Kim, Duberstein, Sorensen, & Larson, 2005).  Other studies have reported much 
lower prevalence rates for the presence of clinically significant depression in lung cancer 
patients (between 4.7-8%), which is likely due to using the Structured Clinical Interview 
for the DSM-III-R (SCID) to assess for depression and to being a Japanese sample 
(Nakaya et al., 2006; Uchitomi et al., 2003).  Also, low rates of depression in lung cancer 
samples have been found when using the strict criteria of “definite depression” when 
using the HADS scale (3%; Myrdal, Valtysdottir, Lambe, & Ståhle, 2003).  LoConte et 
al. (2008) found a significant inverse quadratic trend in depressive symptom severity over 
time in a subsample of lung cancer patients (n = 52), with the highest levels seen at two 
months since the start of the study when using the depression subscale of the HADS.  It 
should be noted that the LoConte et al. study limited the sample to stage IV NSCLC 
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patients.  It is possible that that finding was spurious due to the absence of significant 
quadratic trends being found in other longitudinal studies of depression in lung cancer 
(Hopwood & Stephens, 2000).  However, trends of increasing severity of depressive 
symptoms over time have been found (Henoch, Bergman, Gustafson-Johansson, & 
Danielson, 2007), suggesting a linear increase in depression in lung cancer patients over 
time.  However, When nearing the end of life at advanced stages of lung cancer, it has 
been demonstrated that a significant quadratic relationship exists between levels of 
depression and time to death, where depressive symptoms are at their lowest level of 
severity at 20 months until death and steadily increase in a curvilinear fashion toward 
time of death (Lo et al., 2010).  However, this finding has not been replicated in other 
longitudinal studies that have included depression measures. 
There is evidence that levels of depression are positively related to mortality in 
lung cancer (Buccheri, 1998; Chen, Chen, & Yu, 2010).  However, this finding has been 
debated in the literature with null findings from other studies (Nakaya et al., 2006).  It is 
possible that lung cancer patients who adopt a depressive coping strategy and have lower 
performance status have a shorter life-expectancy (Faller & Schmidt, 2004), indicating 
that it may not simply be the presence of depressive symptoms that predicts shorter 
survival (depression levels as measured by the HADS depression subscale was not a 
significant predictor of survival time in the same study).  It is also possible that the 
contradiction in findings reflects the unknown longitudinal relationship between 
depression, symptom burden, and survival.  Clearly, rigorous longitudinal studies that 
investigate survivorship in lung cancer patients need to be conducted. 
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Anxiety 
Studies that have included anxiety in investigations of psychosocial aspects of 
lung cancer have not explicitly defined anxiety.  It can be inferred from the frequent use 
of specific scales (e.g., the Hospital Anxiety and Depression Scale) that anxiety is 
considered to be a facet of overall distress.  This anxiety refers to subjective feelings of 
worry that give rise to pathological levels of clinical distress. 
Myrdal et al. (2003) found that 43% of the sample of lung cancer patients (n = 
112) met the cutoff for possible clinical anxiety (as measured by the HADS).  Using the 
same measurement, a lower percentage of the lung cancer sample met the criteria for 
definite clinical anxiety in another study (16% of 82 lung cancer patients; Montazeri, 
Gillis, & McEwen, 1998).  In the same investigation, lung cancer patients did not vary 
significantly over time with respect to levels of anxiety from baseline to three months 
later, suggesting a low level of anxiety over time.  However, findings from another 
investigation of anxiety in lung cancer patients (N = 170) suggested that 43.3% of their 
study sample reported clinically significant levels of anxiety (as measured by an author-
constructed scale; Buchanan, Milroy, Baker, Thompson, & Levack, 2010).  Another 
study found that 25% of the lung cancer sample (n = 250) met the cutoff for clinically 
high levels of anxiety (as measured by the Brief Symptom Inventory, BSI; 
Tchekmedyian, Kallich, McDermott, Fayers, & Erder, 2003). 
 
Fatigue 
Often considered one of the most commonly reported symptoms by lung cancer 
patients and survivors, fatigue has been conceptualized as a distressing and subjective 
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feeling of a lack of energy, tiredness, and loss of physical strength.  Rates of fatigue in 
lung cancer are generally at or slightly above half of study samples, ranging from 50-59% 
(Hung et al., 2011; Okuyama et al., 2001; Stone, Richards, A’Hern, & Hardy, 2000).  
However, one study by Hickok, Morrow, McDonald, and Bellg (1996) reported that over 
three-quarters (78%) of the study sample of lung cancer patients who received 
radiotherapy demonstrated clinically relevant levels of fatigue, but this finding is 
questionable due to the retrospective nature of the methodology, using patients’ past 
medical record to assess for fatigue.  One study defined “severe fatigue” as the 95th 
percentile of scores obtained on the Fatigue Severity Scale (FSS) by an age and gender-
matched sample of control subjects without cancer (Stone et al., 2000).  However, 
another study defined “clinical fatigue” as fatigue that interfered with at least one aspect 
of daily functioning, which may be considered more inclusive when compared to Stone et 
al. (2000).  Certainly, efforts need to be made to standardize measurements and generally 
recognized clinical cutoffs for fatigue. 
 
Smoking 
Studies have typically differentiated between current (i.e., currently smoking at 
the time of the study), former (i.e., did not smoke at the time of the study but did smoke 
before), and never smokers (i.e., never smoked before or during the time of the study).  
Former smokers tend to make up the majority of the study samples (37-80.2%), whereas 
current (11.5-50%) and never (8.3-13%) smokers composed smaller fractions of study 
samples (Balduyck et al., 2011; Gonzalez & Jacobsen, 2010; LoConte et al., 2008).  
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Estimates of relapses in smoking post-treatment have varied widely (30-60%; Pinto, 
Eakin, & Maruyama, 2000; Walker, Larsen, Zona, Govindan, & Fisher, 2004).   
Measurements of smoking behavior vary across studies.  Some investigators 
seemed to choose their measures based on a model under scrutiny, such as a model 
consisting of smoking urges and social support (Walker et al., 2004).  Studies have also 
used author-created questionnaires to determine current smoking status, age of first 
tobacco use, and number of pack years (i.e., the number of packs smoked in one day 
multiplied by the number of years as a smoker) of study samples.  Some studies have also 
used biological indicators of smoking status at the time of the study (e.g., urinary 
cotinine; Cooley et al., 2007), using the biological markers as indicators of smoking 
status when discrepancies exist between self-report questionnaires and the biological 
indicators.  Clearly, a consensus on how to measure smoking behavior in lung cancer has 
not been reached.  These differences in measurement may be partly to blame for the 
variability in reported smoking rates in the literature. 
Primary prevention of smoking behavior can substantially decrease the prevalence 
and mortality due to lung cancer because 90% of the cases of lung cancer can be traced to 
the use of tobacco (Alberg & Samet, 2003).  Despite a history of smoking, studies have 
shown that cessation of smoking behavior can reduce the probability of contracting lung 
cancer, having a recurrence of cancer, or dying from the disease (Anthonisen et al., 2005; 
Wu & Sin, 2011).  With the steeper decline seen in tobacco use in men compared to 
women from 1997 – 2006 (Jemal et al., 2008), lung cancer mortality has been declining 
at a greater rate for men than for women.  If such a trend were to continue, women may 
surpass men in the number of cancer deaths.  In summary, lung cancer patients 
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demonstrate a need for interventions aimed at ceasing the use of tobacco, especially in 
female lung cancer patients with a history of smoking. 
 
Stigma and Self-Blame 
Some lung cancer patients attribute the cause of their cancer to their behavior 
(Faller, Schilling, & Lang, 1995) and experience feelings of being labeled as “dirty” or 
“undesirable” (Chapple et al., 2004) because of their identity as lung cancer patients.  
Stigma has been conceptualized as a normative label (Menec & Perry, 1995) that implies 
an undesirable or flawed quality.  This label can be externally imposed by others; in the 
case of the lung cancer patient, others might assume that the individual smoked, which 
contributed to the development of the cancer.  In this way, lung cancer patients may 
perceive that others blame them for their disease.  In one investigation, stigma was 
conceptualized in lung cancer as “health-related stigma,” which is a subjective experience 
of rejection or devaluation based on an identifiable label stemming from a health-
condition (e.g., the label of “lung cancer patient or survivor” and being rejected due to 
that connection with the chronic health condition; Cataldo, et al., 2011).  Interestingly, 
inherent in most investigations of stigma is the concept of self-blame for contracting the 
disease, whether the feeling was imposed by the stigma from others or stemmed from 
personal thoughts or feelings (Faller et al., 1995; Chapple et al., 2004; Cataldo et al., 
2011). 
Self-blame (also, personal blame) has been considered as attributing personal 
responsibility for a given condition (e.g., contracting lung cancer; Faller et al., 1995).  
Not as often studied as stigma, self-blame has been clustered together with stigma 
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(Chapple et al., 2004), More research is needed to establish whether self-blame should be 
studied separately from stigma or if self-blame should be always included in 
investigations of stigma in lung cancer.  
Measurements of stigma and self-blame in lung cancer patients vary across 
studies, making it difficult to compare results.  Complications in interpreting results of 
studies arise from the low availability of measurements that have demonstrated validity in 
lung cancer patient samples.  The Cataldo Lung Cancer Stigma Scale (CLCSS) is the 
only measure of cancer-related stigma that was normed on a sample of lung cancer 
patients (Cataldo et al., 2011).  Four subscales are in this measure: 1) stigma and shame, 
2) social isolation, 3) discrimination, and 4) smoking.  Other measures of stigma, self-
blame, and guilt include the Social Impact Scale (SIS; Gonzalez & Jacobsen, 2010), the 
State Shame and Guilt Scale (SSGS), and the Perceived Cancer-Related Stigma Scale 
(PCRS; LoConte et al., 2008). 
Quantifying the rate of lung cancer patients who experience a clinically 
significant level of stigma or self-blame has begun recently with the availability of 
measures to assess such constructs (e.g., Cataldo et al., 2011).  Implying self-blame, 70% 
of lung cancer patients (while 63% indicated on a questionnaire in the same study) who 
were interviewed attributed their smoking behavior as a cause of their lung cancer (Faller 
et al., 1995).  However, this statistic must be compared to quantitative stigma data 
gathered in future studies of lung cancer samples.  Although, no studies have utilized 
cutoff scores to separate more severe from less severe cases of stigma, self-blame, and 
shame, one study demonstrated that patients with NSCLC experienced a significantly 
higher level of perceived cancer-related stigma relative to breast and prostate cancer 
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patients, but blame and guilt averages did not differ across cancer groups (LoConte et al., 
2008).  Interestingly, blame and guilt scores were predicted by having a history of 
smoking and not by type of cancer. 
 
Interventions Offered to Address Psychosocial Needs 
Available literature documenting the effectiveness of psychosocial interventions 
for lung cancer patients is lacking in comparison to the high level of psychosocial need in 
this cancer population.  Interventions have focused mainly on reductions in distress, 
cessation of smoking, and increase in QoL.  No literature was found on psychosocial 
interventions that target anxiety; depression; and stigma, self-blame, and shame in lung 
cancer patients.  
The effectiveness of interventions targeting psychosocial issues in lung cancer is 
mixed: Interventions aimed at smoking cessation show little or no intervention effects; 
yet QoL, dyspnea (Bredin et al., 1999), and distress interventions generally show 
improvements in the outcomes measured.  For example, a combination supportive care 
and chemotherapy intervention resulted in longitudinal improvements in social and global 
QoL (Helsing, Bergman, Thaning, & Hero, 1998).  Also, a QoL screening intervention 
and early palliative care resulted in more discussion about QoL issues that concerned 
lung cancer patients (Jacobsen et al., 2011; Taenzer et al., 2000; Temel et al., 2010).  
Finally, rates of clinically significant distress (as measured by the DT) were shown to be 
significantly lower in a group who received an extensive distress screening in addition to 
a referral to talk with a member of a psychosocial team (30.7%), when compared to two 
other groups who received either the more extensive distress screening (50.9%) or the 
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minimal screening (51.3%; Carlson, Groff, Maciejewski, & Bultz, 2010).  Given the 
prevalence rates for depression; anxiety; fatigue; and stigma, self-blame, and guilt, it is 
necessary to develop interventions that effectively target those psychosocial issues.  
Additionally, areas of improvement should be identified for interventions delivered (e.g., 
targeting smoking behavior) to increase the treatment effects. 
Response rates have also varied across intervention trials.  Some have reported 
perfect response rates, and other studies have not reported any response rate for lung 
cancer patients who participated (Bredin et al., 1999; Helsing et al., 1998; Temel et al., 
2010).  However, the response rates for most interventions that target improvement of 
psychosocial outcomes in lung cancer are in the range of 33.5-53.3% (Jacobsen et al., 
2011; Porter et al., 2011; Taenzer et al., 2000).  Clearly, the literature on psychosocial 
interventions for lung cancer patients suffers from a lack of reporting the response rates 
of trials.  Since most interventions that include the response rate indicate that about half 
or fewer eligible lung cancer patients participate, the development of future interventions 
may benefit from a qualitative investigation regarding the reasons why lung cancer 
patients decide to not take part in supportive care services offered to them.  Gaining 
insight into the perspective of the lung cancer patient can help direct future development 
of research studies to be tailored more effectively to the needs and preferences of the 
target population. 
In summary, lung cancer patients have a high level of need in multiple 
psychosocial domains, yet it is unknown why eligible patients tend to not participate in 
intervention trials.  It is evident that most lung cancer patients are interested in at least 
one form of supportive care service (91.4%) and about 20% were interested in attending a 
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lung cancer support group (Sanders, Bantum, Owen, Thornton, & Stanton, 2010).  
However, Owen, Goldstein, Lee, Breen, & Rowland (2007) found that only .03% (n = 5) 
of lung cancer patients utilized a cancer-related support group.  Because most (92.2%) of 
those patients perceived benefit from attending a cancer-related support group, 
understanding the barriers to access and maintain engagement in interventions can lead to 
higher rates of utilization of supportive care services that patients typically perceive to be 
beneficial. 
 
Barriers to Access and Maintain Engagement in Psychosocial 
Interventions 
Very little research has been dedicated to exploring the reasons why lung cancer 
patients might experience difficulty in accessing and maintaining engagement in 
psychosocial interventions developed for their needs.  With the exception of one 
investigation of the difference between lung cancer patients’ and support group 
facilitators’ perceptions of barriers to access a support group (Devitt et al., 2010), no 
research has been conducted on this topic for lung cancer.  Although it is likely that 
factors such as high symptom burden, mortality, and not meeting eligibility criteria can 
contribute to hindering lung cancer patients’ involvement in psychosocial interventions, 
such hypotheses have yet to be systematically tested. 
Results from qualitative research suggest several potential barriers to accessing 
and maintaining engagement in interventions.  For example, a lung cancer patient 
reported that she feared that she would be refused cancer treatment because she was a 
smoker (Chapple et al., 2004).  Also, there is some evidence that stigma and self-blame 
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may be related to social isolation (Greene & Banerjee, 2006), indicating that lung cancer 
patients with high levels of personal blame may tend to not seek help for unmet needs.  
Finally, Devitt et al. (2010) found that lung cancer patients perceived the group 
environment, discussing their cancer, parking, and travel as potential barriers to access a 
support group.  However, further evidence must be gathered to better understand what 
drives lung cancer patients’ decisions about participating in available interventions.  
Ideally, an in-depth analysis of lung cancer patients’ difficulties to access and maintain 
engagement in interventions would inform the development of interventions, improving 
the response rates of services offered. 
 
Theories Used to Guide Investigations of Psychosocial Issues 
Overall, the literature on psychosocial issues in lung cancer is lacking guidance 
from theoretical frameworks in the areas of anxiety, distress, and quality of life.  
Although theories have been found to guide investigations in other psychosocial 
constructs, they often vary widely in their usage and focus on different outcome 
variables, complicating comparisons of results across studies.  Investigations of distress 
and anxiety did not report the use of any theoretical models to guide aims and 
hypotheses. 
 
Quality of Life 
Several studies did not identify a theory or model that guided investigations and 
interventions involving QoL in lung cancer patients (Helsing et al., 1998; Langendijk et 
al., 2000; Taenzer et al., 2000; Naughton et al., 2002).  Generally, theoretical orientations 
 20 
are lacking in investigations of QoL, providing little direction for study hypotheses and 
aims, which are often chosen based on previous research that suffers from multiple 
shortcomings already discussed.  One investigation highlighted the lack of theoretical 
orientations used in the psychosocial literature in lung cancer, stating, “With limited 
theoretical perspectives available, researchers also must turn to the empirical literature for 
guidance in study efforts in this important and emerging field” (Fox & Lyon, 2006; p. 
932).  Within this same investigation, the authors incorporated a relatively young 
“theory” that they named “the theory of unpleasant symptoms,” which considers the 
importance of identifying “symptom clusters” as units of analysis when testing their 
effects on other outcome measurements.  The use of the model yielded results from a 
hierarchical “symptom cluster” of depression and fatigue explaining QoL scores (n = 52), 
which concluded with depression explaining a significant amount of the variance and 
fatigue dropping from significance.  Although this result did not provide novel findings, 
further investigations utilizing this approach along with larger samples and many 
different, widely used, and valid measurements may help guide future investigations.  
Theories that incorporate QoL as a factor within their frameworks should be applied 
more often in the literature to guide hypotheses and conclusions drawn from results. 
 
Depression 
No theories or models were applied in several studies (Hopwood & Stephens, 
2000; Kurtz et al., 2002).  However, one study inferred the use of the biopsychosocial 
model to understand the complexity by which depressive symptoms are manifested and 
maintained in lung cancer patients (Lo et al., 2010), emphasizing the multitude of factors 
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that should be considered in predicting depression.  Also, other investigations have used 
attachment and hope theories. 
Attachment theory has been utilized to demonstrate that individuals with chronic 
illnesses who have not developed healthy expectations of and capacity for social 
relationships will likely demonstrate higher levels of depression.  Within this framework, 
investigators (Lo et al., 2010) saw the importance of keeping the integrity of the self in 
the context of advanced cancer, which may help foster higher self-esteem and buffer 
against depressive symptoms.  However, a major limitation in the current use of this 
theory in lung cancer is the lack of longitudinal data from childhood to corroborate 
patient self-report of one’s attachment to a primary caregiver.  Although it may be 
assumed that relationships between the patient and significant others might characterize 
the patient’s quality of attachment early in childhood (a presupposition of this theory), 
this assumption should be confirmed for this population. 
Also, Hope Theory (Snyder, 2002) was applied to a study of depression in lung 
cancer patients, predicting higher levels of depressive symptoms with lower levels of 
hope (as measured by the Adult Hope Scale; Berendes et al., 2010).  Hope Theory is a 
goal-attainment theory, conceptualizing individuals with high levels of “hope” as those 
who can perceive a greater number of methods to obtain a desired goal (i.e., pathways 
thinking) and consider themselves as highly capable of pursuing a goal via the perceived 
pathways to the goal (i.e., agency thinking).  It was found that depressive symptom 
severity was inversely related to levels of hope, implying higher levels of hope predicted 
lower levels of depressive symptomology.  The authors (i.e., Berendes et al., 2010) called 
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for further longitudinal research to investigate whether levels of hope continue to predict 
levels of depression across multiple timepoints. 
 
Smoking 
A model incorporating Appetitive (i.e., desiring positive effects as a result of a 
behavior) and Aversive (i.e., engaging in a behavior to avoid negative feelings or 
consequences) urges as well as Directive and Nondirective social support was 
constructed by Walker et al. (2004) to explain smoking relapse in lung cancer patients 
who completed treatment for cancer.  The theory posits that individuals who did smoke 
will likely relapse into smoking again if an individual has a high reactance (i.e., a 
tendency to reject or oppose advice given from others) and experiences directive social 
support (i.e., advice characterized by being told what to do and giving little choice to the 
recipient of the support) will likely experience high levels of appetitive urges, leading to 
higher relapse rates as well as higher levels of depression.  Although Walker et al.’s 
(2004) findings supported the theory, a low sample size (n = 35) and lack of replication in 
the literature raises questions regarding the strength of the theory and its validity in 
predicting smoking behavior. 
 
Stigma and Self-Blame 
Several studies have guided study hypotheses via attribution theory to explain 
lung cancer patients’ reactions to stigma and self-blame in mixed methods (Faller et al., 
1995) and cross-sectional quantitative research. Menec’s and Perry’s (1995) study was 
helpful in providing information regarding the feelings of anger, pity, responsibility, and 
 23 
willingness of individuals without chronic illnesses (i.e., N = 249 introductory 
psychology students at a Canadian school) to provide aid to younger or older individuals 
of 10 selected “stigmas” (i.e., conditions that are considered undesirable or generally 
looked down upon by society).  As lung cancer was included as one of these stigmas, the 
study provided an opportunity for researchers to understand how an educated population 
of young adults (mostly female) viewed young and old individuals with lung cancer, 
based on level of controllability (i.e., whether the individual with the stigma was able to 
influence its etiology).  The results suggested that older lung cancer patients were viewed 
with significantly more pity and evoked less anger than younger lung cancer patients.  
However, the effect of controllability predicted more pity, less anger, less attribution of 
responsibility, and more willingness to help for lung cancer patients who had scenarios 
that depicted an uncontrollable condition.  The results of this study were corroborated by 
a qualitative study (Chapple et al., 2004), which demonstrated that older lung cancer 
patients did report feeling no blame from others more often when compared to younger 
lung cancer patients in the study and that others viewed their illness as attributable to 
their smoking (i.e., a controllable behavior), even if a patient was never a smoker. 
Faller et al. (1995) used attribution theory to explain that lung cancer patients 
typically attribute the cause of their disease to smoking, implying self-blame and 
initiating a search for ways to reduce cognitive dissonance (i.e., Lung cancer patients see 
that they are to blame for their illness due to their smoking behavior, yet they can readily 
identify other causes for their illness as well, placing less of the blame on themselves and 
reducing dissonance.).  For example, although 70% (when interviewed; 63% reported via 
questionnaire) of the lung cancer patients in the study sample identified smoking 
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cigarettes as a cause (implying their own behavior was to blame), 41% of the sample 
stated that the cause of their lung cancer was not known, suggesting that the placement of 
causal attribution on uncertainty is a method of dissonance reduction.  Although this 
theory seems promising in predicting psychosocial adjustment to lung cancer from causal 
attributions, there is little research with adequate sample sizes and quantitative measures 
validated on samples of lung cancer patients to test the assumptions of this theory in lung 
cancer populations. 
Besides attribution theory, Modified Labeling Theory guided an investigation of 
the relationship between stigma and depression in a sample of lung cancer patients 
(Gonzalez & Jacobsen, 2010).  The theory predicts that lung cancer patients tend to 
blame themselves for their cancer because society has linked lung cancer so strongly with 
tobacco use, which is a controllable behavior.  Therefore, self-blame predicts depression 
in lung cancer patients. 
In the development of the CLCSS, Cataldo et al. (2011) applied a model of 
health-related stigma to conceptualize the effects of social attitudes towards lung cancer 
and perception of personal identity as a lung cancer patient, which leads to negative 
physical and emotional reactions as well as a restructured worldview.  This relationship is 
mediated by the lung cancer patient’s awareness of aspects of stigmatization, which may 
include social disqualification, limited opportunities, and negative change in identity.   
Other studies did not report a theoretical orientation.  These studies appeared to be 
exploratory.  Studies were either qualitative investigations of experiences of lung cancer 
patients (Chapple et al., 2004) or studies guided by previous findings in the literature 
(LoConte et al., 2008). 
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Summary of Psychosocial Needs, Interventions, and Barriers to Engage in 
Interventions 
Overall, the available literature indicates that lung cancer patients generally have 
high levels of need for relief from depression, anxiety, and psychosocial distress.  The 
use of scales with cutoffs for clinically relevant levels of symptom severity for those 
constructs have helped to establish how great the level of those psychosocial needs is.  
Although it is evident that lung cancer patients have psychosocial needs related to 
different psychosocial and physical issues, it can be difficult for literature reviews to 
characterize how high the levels of those needs are and how they relate to study variables 
due to the use of different measurements across studies, a large diversity theories or lack 
thereof to guide investigations, the absence of criteria for clinically relevant levels of a 
given construct as measured by scales, and findings that conflict or are not replicated 
across studies. 
Although it is evident that QoL issues, stigma, self-blame, and smoking behavior 
also represent domains of psychosocial needs for lung cancer patients, it is unclear how 
high the level of needs is due to high heterogeneity of measurements used across studies, 
and the lack of clear cutoffs or criteria for clinically significant levels of a given 
construct.  Future studies should be conducted to determine criteria for low, moderate, 
and high levels of these constructs to facilitate the quantification of clinically significant 
levels of specific constructs in lung cancer patients. 
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Lung Cancer Patients’ Experience of Psychosocial Needs 
Based on current literature regarding psychosocial needs of lung cancer patients, 
there is not a clear understanding of the etiology of lung cancer patients’ needs, the 
predictors of higher levels of needs in a given psychosocial domain (e.g., predictors of 
depression), and what psychosocial needs lung cancer patients consider to be most 
important to them.  Despite the available results from independent investigations, it is 
unclear as to the development of specific psychosocial needs of lung cancer patients due 
to the use of multiple theories within the same domain of psychosocial need as well as 
methodological shortcomings that often limit interpretations of study findings. 
The results found in psychosocial literature on lung cancer research are often 
undermined by small sample sizes, the use of different measurements and 
conceptualizations of the sane construct, and the use of different or no theoretical 
orientations.  These shortcomings limit the generalizability of findings across studies, 
resulting in no clear model, or theory as to the development of any one domain of 
psychosocial needs in lung cancer.  Further complicating the integration of the findings 
between studies is the lack of use of procedures to control for Type I error.  Few studies 
reported the use of such techniques like the Bonferroni correction (Naughton et al., 2002) 
to lower the probability that spurious findings will be reported as significant.  Altogether, 
findings from investigations of psychosocial needs of lung cancer patients are presented 
with few clear conclusions that can be drawn when one reviews the available literature.   
Qualitative studies are certainly more numerous in the psychosocial cluster of 
stigma, personal blame, and shame in lung cancer patients, which may help explain how 
investigations in this domain are set in the context of theories (e.g., attribution theory) 
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more often than other investigations within other domains of psychosocial needs in lung 
cancer patients.  Certainly, it seems that early studies by Faller et al. (1995) and Menec 
and Perry (1995) helped establish the use of theories in investigations of stigma and self-
blame, which later studies by Cataldo et al. (2011) and Gonzalez and Jacobsen (2010) 
continued.  Future studies that utilize a qualitative methodology to gather and analyze 
interview data may be beneficial to help elucidate the experience of lung cancer patients 
who have high levels of various domains of psychosocial needs. 
 
Lung Cancer Patients’ Levels of Interest in Psychosocial Services 
Little is known about lung cancer patients’ levels of interest in specific types of 
psychosocial interventions and what factors predict interest levels.  There is limited 
evidence currently available that points to a majority of lung cancer patients in a study 
sample who desire information about their disease and its treatment as well as exercise-
related information and support (Sanders et al., 2010).  Low response rates from eligible 
lung cancer patients may reflect several possible conclusions, such as a low interest in the 
type of service or how it is delivered.  A qualitative study of lung cancer patients’ 
perspectives regarding the preferred characteristics of psychosocial interventions may be 
necessary to formulate hypotheses as to the reasons why low response rates are observed 
in lung cancer-specific psychosocial interventions. 
 
Barriers to Engage in Psychosocial Interventions 
Across intervention studies involving lung cancer samples, there is generally low 
response rates may indicate that there are significant barriers to engage in psychosocial 
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interventions.  However, little research has been conducted to investigate this possibility.  
Evidence is only available for barriers to access and engage in smoking cessation 
interventions for smokers (Roddy et al., 2006) and for demonstrating a potential barrier in 
significant discrepancies between perspectives of lung cancer patients and those who 
facilitate supportive care services (Devitt et al., 2010).  Overall, specific evidence that 
elucidates the experience of lung cancer patients’ troubles in accessing psychosocial 
interventions is lacking.  This gap in the literature may be filled by a qualitative 
investigation involving a sample of lung cancer patients and utilizing a grounded theory 
approach, similar to the investigation conducted to explore smokers’ perspective 
regarding barriers to access and maintain engagement in a smoking cessation intervention 
(Roddy et al., 2006). 
 
Developing Effective Interventions: The PRECEDE-PROCEED 
Model 
The PRECEDE-PROCEED model of intervention development will be utilized as 
the context by which the proposed study will take place.  It was chosen because it 
considers a subjective assessment of the experience of the target population (i.e., the 
individuals for whom an intervention’s effect is intended) as the first phase of a multi-
step process of developing effective interventions.  Since the literature is lacking on 
perspectives of lung cancer patients regarding how they experience psychosocial issues, 
what psychosocial interventions interest them, and what barriers they perceive as 
impeding their engagement in available interventions, a model that incorporates an 
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assessment of the target population’s perception of their needs as a part of developing 
effective interventions was an ideal framework in which the proposed study could be set. 
The PRECEDE-PROCEED model has been used as a framework for building 
effective psychosocial interventions (Green & Kreuter, 1999).  The PRECEDE-
PROCEED Model of health promotion planning is considered “a theoretically ‘robust’ 
model that addresses a major acknowledged need in health promotion and health 
education: comprehensive planning” (pp. 35-36).  Numerous health departments, 
randomized clinical trials, and other health projects have implemented PRECEDE-
PROCEED.  Also, a variation of the PRECEDE-PROCEED model has been 
recommended by the American Lung Association as a Program Planning and Evaluation 
Guide for Lung Associations (L. W. Green, 1987).  A brief description of the first two 
phases of the model will illuminate a weakness that exists within the process of 
development, implementation, and evaluation of psychosocial interventions that target 
the population of lung cancer patients: Interventions are too often implemented without a 
continuous subjective needs assessment of the participants involved.  Indeed, Green and 
Kreuter (1999) state that two foundational pieces of information for sound intervention 
development are the subjective needs and the health problems of the target population.   
Phase one and phase two of the PRECEDE-PROCEED model address the 
subjective concerns of the target population (phase one) and allow those to inform the 
ranking of relevant threats to health (phase two; Green & Kreuter, 1999).  Although it 
may be necessary for some health care professionals to develop programs without the 
benefit of enough time or resources to begin an intervention assessment through 
subjective evaluation by the target population, the concerns of patients should be a vital 
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resource to help inform the dynamic growth of such programs throughout every phase.  
Without the guide provided by the views of lung cancer patients, psychosocial 
interventions may develop a myopic understanding of the entire context of health needs 
(medical and psychological) that are most pressing in their minds.  In her editorial 
concerning the use of theory in health promotion, Green (2000) warned of the danger 
inherent when health promotions are completely guided by amassing empirical data on 
the effectiveness of given interventions.  She argued, “Of more relevance to the 
practitioner are general principles together with an understanding of context-specific 
factors, which will allow adaptation to suit different situations” (p. 129).  She posited that 
the inclusion of such factors in the design and implementation of interventions would 
help avoid “type III error,” which is defined as “the rejection of the effectiveness of a 
programme when the programme itself was inadequate in terms of design or delivery” (p. 
126).  Essentially, attention must not only be placed upon the evaluation methodology, 
but care is to also be taken in the development of quality psychosocial interventions.   
In the case of lung cancer patients, it is then of great importance to ascertain 
which psychosocial interventions they would consider most helpful.  It is apparent that 
investigators are delivering interventions that are either of little interest to lung cancer 
patients or are delivered without regard to barriers that the target population perceives.  In 
light of the call for psychosocial interventions that are contextually relevant and 
theoretically grounded, an assessment of the unique psychosocial needs of lung cancer 
patients is necessary and has begun with such investigations by Sanders et al. (2010) and 
Devitt et al. (2010). 
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The Importance of the Target Population’s Perspective in Current 
Lung Cancer Intervention Development 
Carlsen and colleagues (2005) have discussed that lung cancer patients may 
benefit from tailored interventions, which are specific to the socio-cultural context of the 
target population (p. 299).  Interventions that are constructed to mesh with the unique 
backgrounds of diverse patient populations must be guided by subjective needs 
assessments because different patient populations inevitably comprise different 
composites of individual cultural backgrounds.  As the PRECEDE-PROCEED model 
suggests, the development of effective psychosocial interventions for lung cancer patients 
must begin with an understanding of the needs that they consider to be most important.  
As Carlsen and colleagues (2005) suggest, this may be accomplished through standard 
psychosocial screening of lung cancer patients, which can provide a clearer picture of 
which psychosocial interventions may prove to be most beneficial or should be offered.  
Although Carlsen and colleagues (2005) make this suggestion for the purpose of 
identifying lung cancer patients who are depressed and are at risk for depression, a 
comprehensive psychosocial screening instrument can help identify an array of needs that 
can be met with the appropriate intervention (Taenzer et al., 2000).  This scenario (i.e., 
using a standard psychosocial screening instrument) may prove beneficial in healthcare 
settings that already possess a wide array of available psychosocial services for cancer 
patients.  However, if novel psychosocial interventions need to be developed, then it 
would be beneficial to conduct a subjective needs assessment, which can be comprised of 
qualitative methods to capture in-depth patient perspectives.  If a psychosocial 
intervention is guided by the goal of meeting those pertinent needs, then the intervention 
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will be more likely to demonstrate a higher level of effectiveness or efficacy, depending 
on the setting of the intervention. 
 
Study Aims 
The study addressed the following three aims, which are stated as research 
questions (Strauss & Corbin, 1998): 1) Which psychosocial needs do lung cancer patients 
consider to be the most important, 2) what are the barriers that lung cancer patients 
perceive as hindering them to engage in a psychosocial intervention, and 3) which 
methods of delivering psychosocial interventions are most desired by lung cancer 
patients?  Since these questions address a poorly understood domain of the research 
literature, and the focus of the study was rooted in the concerns (or perspectives) of the 
subjects (Strauss & Corbin, 1998); the study utilized qualitative methodology – guided by 
a grounded theory design – to explore how lung cancer patients perceive their 
psychosocial needs, the psychosocial interventions that are available to them, and the 
barriers that impede accessing and maintaining engagement in interventions. 
 
Study Design 
In an attempt to understand the psychosocial needs of lung cancer patients and 
how healthcare professionals can meet those needs, a qualitative design guided the 
research process for this study (Strauss & Corbin, 1998).  Akin to other studies that 
utilized a grounded theory approach (e.g., Badr & Taylor, 2006), the study analyzed the 
qualitative data gathered with the goal of deriving an explanation that addressed the aims 
of the study.  Since grounded theory (GT) designs have been utilized to compose a theory 
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of processes common across the subjects involved in the study (Creswell et al., 2007), the 
proposed study implemented a GT design to elucidate shared phenomena across the lung 
cancer patients that will be included in the study.   
The GT approach was implemented to guide the investigator towards a theory that 
will emerge from the qualitative data.  As grounded theory is an approach that begins 
with the collection of data, which is then followed by immersion into the data and the 
subsequent emergence of theory, Strauss and Corbin (1998) describe the proper approach 
to carrying out studies that implement a grounded theory design. 
Using the grounded theory approach to analyze the qualitative data, it was 
imperative for the investigators to examine the subjects’ responses without projecting 
personal perceptions or biases regarding the actual content of the responses or the theory 
that will be built at the conclusion of the study.  Although they admit that absolute 
objectivity is impossible, Strauss and Corbin (1998) emphasized the importance of 
objectivity during a qualitative analysis of the data, especially within a study that is 
guided by the grounded theory design.  When focusing on the concerns of the subject, it 
was crucial to design and deliver the interview schedule from a neutral orientation, which 
is not influenced by heuristic knowledge or expectations regarding the theory that will 
emerge.  If an investigator approached the data with biases (e.g., about the nature of the 
subjects or the theory that is expected to emerge) that influence the development of the 
interview schedule and interactions with the subjects, then it would be likely that the 
emergent theory will not accurately reflect the perspective of the subjects.  With the 
importance of objectivity in viewing the data at the forefront of the investigator’s 
concern, the study was approached with a GT design. 
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CHAPTER TWO 
METHOD 
 
Subjects 
Since the theoretical population for this study will be lung cancer patients in the 
USA, a sample of lung cancer patients was recruited from the accessible population of 
lung cancer patients who were registered in the Loma Linda University Medical Center 
(LLUMC) cancer registry (i.e., the sampling frame).  The investigators decided to sample 
from the LLUMC cancer registry because the lung cancer patients who are found in the 
cancer registry are thought to be representative of lung cancer patients treated at cancer 
centers throughout the United States. 
The investigator aimed to recruit a sample of 20-30 lung cancer patients for the 
study.  This number of subjects matched the number provided within the example of a 
grounded theory-guided study in Creswell and colleagues’ (2007) overview of qualitative 
research designs.  At this number of subjects, the emergent theory should be saturated 
with qualitative data such that further data collection from additional lung cancer patients 
would provide no more substantive or unique information about the perspective of lung 
cancer patients in the LLUMC cancer registry. 
 
Sampling Strategy 
After screening the LLUMC cancer registry for patients with lung cancer, the 
manager of cancer outcomes and quality at the Loma Linda University Cancer Center 
(LLUCC) emailed only the portion of the registry that includes outpatient cases, inpatient 
cases, and emergency visits of cancer patients diagnosed with lung cancer on a monthly 
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basis.  The investigator selected those patients who have not already been included in an 
IRB-approved ongoing study of psychosocial adjustment to lung cancer (see Sanders et 
al., 2010) and requested contact information (i.e., phone number(s) and mailing address) 
for those selected patients through the manager of cancer outcomes and quality.  Once the 
contact information was obtained, the investigator called the lung cancer patients and 
requested their consent to participate in the ongoing study via telephone.   
The inclusion criteria of the proposed study included the following: 1) a diagnosis 
of lung cancer, 2) completion of the baseline questionnaire of the ongoing study, 3) the 
ability to understand written and verbal English, 4) the ability to speak in English, 5) an 
indication that the subject would be interested in participating in future research 
(determined by the subject’s response to an item in the baseline questionnaire of the 
ongoing study), 6) the expressed verbal consent from the subject, and 7) the completion 
of the entire interview schedule.  Individuals were excluded from the study if they did not 
meet all of the inclusion criteria. 
It was expected that the sample recruited for the proposed study would closely 
resemble the demographics found in the study conducted by Sanders and colleagues 
(2010) because both studies indicate that the sample is selected from accessible 
populations from hospitals in southern California, one of which is from the same hospital 
(LLUMC).  If demographic characteristics of the sample did not change significantly 
since the study by Sanders and colleagues (2010), then it was expected that the sample of 
lung cancer patients in the proposed study were typically be older (M = 68.5 years, SD = 
10.1 years), about evenly distributed between sexes, had an education almost at the high 
school level (M = 13.5 years, SD = 2.6 years), mostly composed of Caucasian subjects 
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(77.4%), had a little over a year’s time lapse since initial diagnosis (M = 54.1 weeks, SD 
= 63.6), and would typically be diagnosed at a later stage (stages III & IV: 44.8%; stages 
I & II: 24.7%; stage unknown: 30.5%).  In the proposed study, demographic 
characteristics regarding the subjects’ age, sex, years of education, ethnicity, time since 
diagnosis, type of lung cancer, and stage of disease were reported. 
It is also important to consider that subjects included in the proposed study were 
considered by Rosenthal and Rosnow (2008) to be “second-level volunteers” (i.e., The 
sample recruited for the proposed study consisted of a sample from the “volunteers” in 
the ongoing study.).  Therefore, it was important to compare the demographics of those 
who agree to participate in the proposed study to those who were eligible to participate 
but choose not to be interviewed for the proposed study.  That comparison demonstrated 
whether the sample of lung cancer patients in the proposed study represents a biased 
sample compared to those who were eligible but did not participate.  Specifically, chi-
square (for tests involving categorical variables) and t-tests (for tests comparing 
continuous variables) comparing demographic information between the those who opted 
not to participate in the proposed study (despite being eligible) and those who completed 
the interviews informed the investigator whether the study sample was externally valid to 
the available population of lung cancer patients. 
 
Study Setting and Materials 
The proposed study was conducted in the Behavioral Oncology Laboratory (BOL) 
at Loma Linda University.  Specifically, all telephone calls to eligible participants, 
storage of recorded interviews, transcriptions of interviews, and qualitative analysis of 
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the interview data took place in the BOL.  The BOL was considered secure because two 
separate keys for two different doors were required to access the laboratory. 
 
Interviews 
The interviews were recorded via a digital recorder, which were connected 
directly to the telephone line.  During the administration of the interview, the investigator 
referred to an interview protocol (see Appendix) to standardize the interview format.  
Recordings captured words from both the investigator as well as the participant.  Since 
the recorder was outfitted with a built-in USB interface, each recorded interview was 
downloaded and saved onto Apple i-Tunes software to be played back for the purpose of 
transcribing the interview verbatim.  Transcriptions were be typed and saved onto 
Microsoft Word documents to facilitate the printing of the multiple copies necessary for a 
qualitative analysis (Strauss & Corbin, 1998).  All hardcopies of the transcripts were 
stored in a file cabinet within the Behavioral Oncology Laboratory (BOL).  All 
recordings of the interviews were saved on a password-protected hard drive.  At the 
conclusion of the study, the saved recordings were erased from the hard drive; and no 
copies of the interviews were retained (in either paper or digital format). 
 
Interview Protocol 
The interview protocol included a script that the investigator used to greet the 
participant, inform the participant about the purpose of the interview, and conduct the 
recorded interview (see Appendix).  The interview protocol contained separate scripts 
depending on patient responses to questions regarding participation (e.g., If the patient 
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responds with “Yes,” then reply…”) as well as a script for calls made on the day of a 
scheduled interview (i.e., If a participant wishes to reschedule the interview, a different 
script is provided to the investigator to use for such a call.). 
The interview schedule was in a semistructured format; qualitative data was 
gathered from participants’ responses to open-ended questions (e.g., “When you think 
about it, what types of needs do you usually require help with?”) and fixed questions 
(e.g., “On a scale from one to ten, one being little to no interest and ten being extremely 
interested, what is your level of interest in the following ways of meeting your needs…”).  
A list of recommended probes appeared at the bottom of the interview schedule to query 
for more information about a response.  The semistructured format was chosen to allow 
for variability in individual responses and to facilitate a standard method of administering 
the recorded interview.  The content of the questions included in the interview schedule 
were generated to address the three aims of the proposed study.  Specifically, the first 
three sections of the interview schedule (see Appendix) addressed the three aims of the 
study, and sections 4 and 5 are supplemental to qualitative data from the three previous 
sections. 
 
Procedure 
A flowchart of the recruitment of participants over the course of the current study 
can be viewed in Figure 1.  Investigators attempted to recruit lung cancer patients who 
have completed the baseline questionnaire of the ongoing study in a two-step process: 1) 
An envelope containing a consent sheet and a letter explaining that a researcher will be  
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Figure 1. Flowchart of recruitment and attrition in the current study. 
 
 
calling within the next two weeks will be mailed to the potential participant, and 2) an 
investigator will call the potential participant within two weeks. 
After sending the letter to the potential participant, an investigator attempted to 
contact him/her by telephone.  If the lung cancer patient answered the call, then the 
investigator determined whether he/she is willing and able to participate in the proposed 
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(n = 13)
Complete Interview
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Unwilling/unable to 
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study.  However, if the patient did not answer the call, two more attempts were made to 
contact the potential subject before his/her name will be dropped from the list of eligible 
participants to contact.  Also, if a participant wished to opt out of the proposed study, 
he/she was not contacted again regarding participation in the proposed study. 
If the participant was willing to participate yet needed to reschedule the interview 
for a later date, then the investigator asked for another time that will work for 
interviewing the patient.  The investigator then contacted the participant on the desired 
day and time that was mutually agreed upon by both the investigator and the participant.  
If the patient was no longer willing or able to participate in the proposed study, then the 
investigator no longer contacted him/her. 
Before the interview was conducted, participants were reminded that they have 
the option to opt out of the interview and end their interview session at any time.  
Recordings of any interview sessions in which the patient opted out in the middle of the 
interview was immediately erased and not used in the qualitative analysis of the data.   
When the interview was conducted, a semistructured interview format was 
utilized to provide some standardization of responses directed towards the aims of the 
proposed study.  However, some flexibility was provided in patient responses by open-
ended questions to explore the perspective of the population, which may have been 
missed if more fixed questions were asked.   
Just prior to beginning the interview, the investigator was cued by the interview 
protocol to begin recording the interview.  A digital recorder recorded the two-way 
discourse between the investigator and the patient.  The recorder was connected directly 
to the telephone line to capture the entire interview.  After the interview was complete, 
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the investigator was cued by the interview protocol to stop the recording of the telephone 
conversation between the researcher and the patient. 
Utilizing the built-in USB interface of the digital recorder, the investigator 
downloaded the audio recording data onto Apple i-Tunes in .mp4 format.  Each separate 
participant’s recording was saved onto different audio files, using their identification 
numbers from the ongoing study (i.e., the same identification number that appears on the 
baseline questionnaire they completed in the ongoing study) to indicate which recording 
belonged to a given participant.  Once the audio recordings were saved onto i-Tunes, the 
investigator played them back through headphones and transcribed them onto Microsoft 
Word documents.  The patients’ identification numbers from the ongoing study was also 
used in the names of the saved Word documents.  All digital recordings and Word 
documents pertaining to the proposed study were saved onto a password-protected hard 
drive in the BOL.  The transcriptions of the recordings were printed for the purpose of a 
qualitative analysis of the interviews.  All printed transcriptions were kept within a file 
cabinet within the BOL. 
Also, demographic information from the baseline questionnaire of the ongoing 
study were used in a quantitative analysis.  The IBM Statistical Package for the Social 
Sciences version 19 (SPSS) was utilized in the quantitative analysis portion of the 
proposed study. 
At the conclusion of the current study, all digital audio recordings and 
transcription files saved onto the password-protected hard drive were erased.  Also, all 
printed transcriptions of the interviews were destroyed at the current study’s completion. 
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Demographic Information 
A questionnaire was used to assess sex, age, education level, level of income, 
lung cancer type, stage of cancer, time since diagnosis, and smoking status. 
 
Supportive Care Needs Survey (SCNS) 
The SCNS is a 31-item measurement of the level of perceived need, which uses a 
five-point Likert scale that ranges from 1-5.   The range of scores for each individual item 
can be split between the 1-2 range as having no need for the item (1 = “not applicable” 
and 2 = “satisfied”) and the 3-5 range as having some level of need represented by the 
item (3 = “low need,” 4 = “moderate need,” and 5 = “high need”).  The overarching 
factor (Total Supportive Care Needs [TSCN]) was used.  This scale has been shown to be 
a reliable instrument when used in samples of cancer patients (Li & Girgis, 2006; Sanders 
et al., 2010).  The internal consistency of this measure was acceptable in the current 
study,  = .79. 
 
Data Analysis 
Analysis of the data obtained for the proposed study involved quantitative and 
qualitative data: 1) Analysis of quantitative data obtained from the information provided 
in the baseline questionnaires of the ongoing study and 2) analysis of qualitative data 
from the interviews. 
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Quantitative Data Analysis 
The purpose of the quantitative analysis portion of the proposed study was to 
determine whether selection of participants were biased based on demographic 
characteristics and total supportive care needs (TSCN).  If the study sample was not 
significantly different across demographic characteristics and TSCN when compared to 
eligible patients, then it was assumed that the selection of participants was not biased.  
However, if significant differences in demographic characteristics were found, then the 
results of the qualitative analysis would be interpreted with caution, and it would be 
noted that the results from the qualitative analysis might be unique to the sample of 
patients who participated in the study.   
Demographic characteristics that were included in the analyses are the following 
variables: sex (male or female), age, ethnicity (Caucasian or other ethnicity), weeks since 
diagnosis, type of cancer (non-small cell, small cell, or not sure), and stage of cancer 
(Stages I, II, III, IV, or not sure).  Chi-square analyses were used to test for differences 
between the patient who completed interviews and those who were eligible and opted out 
of the study or could not be contacted on categorical demographic variables (i.e., sex, 
ethnicity, type of cancer, and stage of cancer).  Continuous demographic variables were 
assessed by one-sample t-tests, using the means from the larger sample of lung cancer 
patients as the theoretical averages of the population (i.e., age, weeks since diagnosis, 
education, and TCSN).  The significance level was set at  = .05. 
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Qualitative Data Analysis 
An outline of the method used to analyze the qualitative data is shown in Figure 2 
(p. 45).  The analysis of the interview data was guided by a GT design, specifically 
utilizing the methodology from Strauss and Corbin’s Basics of Qualitative Research: 
Techniques and Procedures for Developing Grounded Theory (1998).  Since the current 
study addressed three aims, qualitative data gathered from sections 1, 2, and 3 from the 
interview schedule (see Appendix) will be analyzed separately to directly address each 
separate aim. Responses from section 4 of the interview schedule was considered 
supplemental data to section 2 because it may provide additional data regarding lung 
cancer patients’ preferences for psychosocial interventions.  Any data from section 5 of 
the interview (i.e., “Are there any other things that you would like to mention before we 
end the interview?”) was only considered supplemental data to answer the three aims of 
the proposed study if it was considered relevant and was apparent how the response 
related to a given study aim.  
First, a qualitative analysis of the interview transcripts began with a line-by-line 
analysis of the content of the patient responses to queries from the interview.  Categories 
(i.e., phenomena) were conceptualized during this sequential analysis and were informed 
by the context of the response content around each phenomenon identified as well as by 
the context of the patient (e.g., adjusting to the treatment and diagnosis of lung cancer). 
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Figure 2. Process of qualitative data analysis used in the current study. 
 
 
Second, the transcripts were reviewed again for the purpose of recording memos 
regarding the range of potential meanings within the responses given by the patients.  The 
investigator specifically commented on the potential meanings of the responses as they 
related to the categories identified in the line-by-line analysis of the transcripts.  Once 
Step 5: An experienced qualitative investigator independently reviewed 
identified phenomena
Agreement between reviewers determined the final set of categories
Step 4: Axial coding
Concepts were refined according to commonly expressed dimensions or 
properties of that phenomena
Step 3: Labeled phenomena were reviewed
Concepts were consolidated into broader or more abstract phenomena
Step 2: Memos written
Range of potential meanings of initial concepts informed the labeling of 
phenomena
Step 1: Line‐by line analysis
Initial concepts and phenomena were formed
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memos were recorded for each transcript, phenomena were labeled according to themes 
that were shared across the patient’s responses. 
Third, the accumulated concepts (i.e., phenomena) were reviewed for the purpose 
of consolidating phenomena that may be grouped under a broader concept.  Grouping of 
related concepts occurred in one of two ways: 1) Two or more concepts related to each 
other under a single category (e.g., Difficulty driving and difficulty taking public 
transportation to a site of treatment can be categorized under a “Transportation Barrier” 
phenomenon.), or 2) more abstraction was be necessary to consolidate a high number of 
phenomena from the line-by-line analysis and memos (e.g., five or more categories relate 
to the abstract concept of “Financial Problems”).   
Fourth, axial coding was used to determine whether certain properties or 
dimensions of identified phenomena could be grouped to form concepts.  For example, if 
the content of patient responses that formed a category involved a commonly expressed 
dimension, then that property would be included in the label of the phenomenon. 
Fifth, the identified concepts (i.e., phenomena) were used to assess inter-rater 
reliability.  An experienced qualitative investigator independently assessed how the 
identified concepts are expressed within the content of the patient responses.  
Specifically, the qualitative investigator determined which phrases or sentences indicated 
the identified phenomena and whether additional or fewer categories were necessary.  
Discrepancies amongst the panel were resolved in a group meeting in which the final 
group of identified phenomena was decided. 
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CHAPTER THREE 
RESULTS 
 
Characteristics of the Study Sample 
Out of 230 lung cancer patients who completed the baseline survey of the ongoing 
study, 37 (16.09%) were approached for participation in the study.  Out of those who 
were approached, 3 (8.11%) were deceased, 21 (56.76%) were contacted to schedule an 
interview, and 17 (45.95%) scheduled an interview.  Of those who scheduled an 
interview, 4 (23.53%) could not be reached for the follow-up interview and 1 (5.88%) 
opted out of the study.  The study sample was composed of 12 lung cancer patients who 
completed interviews (see Figure 1).   
Table 1 (p. 48) shows the demographic characteristics of the study sample in 
comparison to the larger sample that completed at least one baseline survey.  Chi-square 
and one-sample t-tests demonstrated that the patients that were interviewed did not 
significantly differ from the larger sample by sex, age, ethnicity, education, lung cancer 
type, stage of cancer, weeks since first diagnosed, and Total Supportive Care Needs.  The 
study sample (n = 12) was composed mostly of non-Hispanic white (91.7%), female 
(58.3%) patients who were typically diagnosed with non-small cell lung cancer (72.7%) 
and were uncertain of the progression of their cancer (41.7%).  Although participants 
were diagnosed less often at stages III (8.3%) and IV (16.7%) compared to the larger 
reference group (18.5% and 30.8% diagnosed at stages III and IV, respectively), the 
difference was not significant.  They were elderly (M = 68.33 years, SD = 7.75 years) but 
younger than the median age (71 years) for individuals with lung cancer between  
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Table 1 
Demographic and Medical Characteristics of the Study and Reference Samples. 
 Study Sample  (N = 12) 
Reference Sample  
(N = 230) 
Variable n(%) n(%) 
Sex   
    Male 5(41.7%) 94(43.1%) 
    Female 7(58.3%) 124(56.9%) 
Ethnicity   
    White 11(91.7%) 169(80.1%) 
    Other 1(8.3%) 42(19.9%) 
Type of lung cancer   
    Non-small cell 8(72.7%) 107(56.3%) 
    Small cell 2(18.2%) 53(27.9%) 
    Other 0(0%) 28(14.7%) 
    Don’t know 1(9.1%) 2(1.1%) 
Stage of cancer   
    I 1(8.3%) 31(14.7%) 
    II 3(25.0%) 18(8.5%) 
    III 1(8.3%) 39(18.5%) 
    IV 2(16.7%) 65(30.8%) 
    Don’t know 
 
5(41.7%) 58(27.5%) 
 M(SD) M(SD) 
Age 68.33(7.75) 66.95(10.64) 
Education 12.67(2.71) 13.48(2.69) 
Weeks since first 
diagnosed 
72.83(108.00) 51.14(72.96) 
Total supportive care needs 2.34(0.70) 2.54(0.73) 
Note. Discrepancy from the total sample of the Reference Group (N = 230) and totals for 
each category due to missing data within those categories. 
 
 
2004-2008 in the United States (SEER; Howlader et al., 2012).  Time since their initial 
diagnosis varied greatly from an average of about 18 months (M = 72.83 weeks, SD = 
108.00 weeks).  Total supportive care needs were between the level of “met need” and 
“low need” (M = 2.34, SD = 0.70). 
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Findings from the Interviews 
From the 12 interviews that were included in the study, emergent themes and 
categories were recorded in a codebook.  Themes were organized according to each aim 
of the current study: 1) determining the most pertinent psychosocial needs of lung cancer 
patients, 2) describing perceived barriers in meeting their needs, and 3) evaluating their 
level of interest for different methods of delivering psychosocial interventions.  Three 
themes emerged under the first aim (No Current Psychosocial Need, Physical and 
Medical Needs, Current Psychosocial Needs), six themes emerged under the second aim 
(Time Constraint, Limited Income, Travel, Lack of Information, Anxiety, Limited 
Motivation/Necessity), and different numbers of categories emerged under the five 
themes (Internet, Face-to-Face, Support Group, Telephone, Personal Effort) of each 
intervention method explored during the interview.  All transcripts were double-coded 
and checked for inter-rater reliability.  Consistency between raters was considered 
acceptable, kappa = 0.84. 
 
The Most Pertinent Psychosocial Issues of Lung Cancer Patients 
When asked about their needs beyond just medical care, almost half (41.7%) of 
the study participants indicated that they either never had any psychosocial need or did 
not currently have a need.  However, by the end of the interview, every participant 
mentioned at least one category pertaining to a specific psychosocial need.  Also, specific 
physical and medical needs were reported by more than half (66.7%) of the study sample.  
Figure 3 (p. 50) shows each category of psychosocial need that was reported.   
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Figure 3. Frequency of psychosocial issues reported by the study sample. 
 
 
Psychosocial issues that were reported by half or more of the interviewed lung cancer 
patients were disease and treatment-related information (75.0%), fatigue (58.3%), and 
anxiety about future medical exam results or cancer recurrence (50.0%).  Almost one-half 
(41.7%) of the patients stated that staying positive or seeking the positive in their 
situation was important (e.g., “It’s a good thing for people who have cancer to have a 
positive perspective.”).  The same percentage of participants reported that nutrition or 
exercise-related information and support was important to them.  One-third of the study 
sample (n = 4) reported depressed mood (e.g., “I guess I depress once in a while when I 
think about my cancer.”) and difficulty understanding the underlying cause of specific 
symptoms (e.g., “I guess right now we’ll be limbo again until we determine what is the 
cause of the symptoms I’m having.”).  One-quarter of the participants (n = 3) indicated 
that pain sensations and adjusting to life with cancer (e.g., “Is this life going to be forever 
like this?  Okay, I’m living, but it has got a lot of restrictions.”) were problematic.  Most 
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participants (75%) indicated that they utilized some strategy to address their psychosocial 
need, which included spiritual (e.g., “I pray a lot.”), family and friends (e.g., “Well, like I 
have mentioned before I have a very nice circle of friends. During those periods of time, I 
had a lot of support from them.”), professional support (e.g., “Well, I’m in physical 
therapy for pulmonary cardio therapy.”), and personal effort (e.g., “I do most everything 
for myself.”) strategies. 
 
Barriers that Hinder Engagement in Psychosocial Interventions 
Except for one lung cancer patient, participants perceived at least one barrier that 
might hinder meeting their psychosocial needs.  Descriptions and examples of the 
emergent themes of barriers are displayed in Table 2 (p. 52). 
Barriers related to the theme of Time were reported most frequently (n = 6, 
50.0%), which involved being busy and having difficulty with scheduling times that 
would work for the patient.  Almost one-half (41.7%) of the participants stated that 
categories related to the theme of Travel (i.e., travel expense, inability to drive, long 
distance) were barriers to meeting their psychosocial needs.  One-third (n = 4) perceived 
that Finance/Income problems and limited Necessity/Motivation served as barriers.  Two 
participants (16.7%) reported that categories related to the theme of Anxiety (i.e., fear of 
cancer recurrence, not wanting to bother others for support) hindered their seeking for 
help.  Another two patients stated that a barrier was Lacking Information about what a 
psychosocial intervention might entail.  Barrier themes and their frequency of emergence 
in the study sample are displayed in Figure 4 (p. 53). 
 
 52 
Table 2 
Emergent Theme Descriptions and Examples of Barriers to Intervention Engagement. 
Theme Description Interview example 
Time There are too many demands for one’s 
time, and it may be too difficult to 
schedule attendance for an intervention. 
“You still got family to take 
care of, things to do, errands 
to run.” 
“I have to adjust my 
scheduling to work around 
that.” 
Travel The process of arriving at the site where 
the intervention takes place might be 
problematic due to the long distance 
from one’s residence, the cost of travel, 
or limitations in ability to drive a 
vehicle. 
“I’m not driving because of 
this sleepiness and other 
problems I am having.” 
“With gas prices and things 
like that, it’s hard to go 
anywhere anymore.” 
“I got tired of going there.  It’s 
too far from me.” 
Necessity/motivation The patient perceives that their 
likelihood of attending an intervention 
is directly related to their level of need 
and motivation to engage in an 
intervention. 
“Sometimes when I got into, 
‘oh I think I’m going to do 
this,’ then I think about it a 
while longer and then I don’t 
do it anymore because my 
motivation isn’t as strong as it 
was 2 weeks before or 
whatever.” 
“I don’t feel like I need it.” 
Finance/income The chance of attending an intervention 
is lower due to financial burden or low 
income. 
“When you get sick like this, 
your bills go up and your 
income goes down.” 
Anxiety A manifestation of worry or anxious 
feeling is bothersome and lowers the 
likelihood of intervention attendance.  
Anxious feelings might be caused by 
fear of cancer recurrence or worry that 
receipt of assistance will be a bother to 
others. 
“Always in the back of my 
mind is just how is it gonna 
come back again and get 
worse.” 
“I really don’t want to put 
other people…make them 
have to run back and forth for 
me because I don’t think that 
is fair.  I don’t like to bother 
people.” 
Lacking information Prior knowledge of an intervention, 
such as how it is delivered and what 
might be expected of intervention 
attendees, affects interest. 
“My enthusiasm would 
probably be a lot better or a lot 
worse if I knew exactly what it 
pertains to.” 
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Figure 4.  Frequency of barriers reported by the study sample. 
 
 
The Most Desired Methods of Psychosocial Intervention Delivery 
Participants were asked to rate their level of interest (using a 1-10 scale) in 
receiving psychosocial services through the following modalities: Internet, face-to-face, 
support group, telephone, and personal effort (i.e., no external support).  After providing 
their interest rating, the interviewer asked patients for their rationale, which led to the 
emergence of categories under each intervention theme (i.e., mode) to help explain why 
individual patients might assign a certain magnitude of interest.  Average interest levels 
for intervention methods explored in the study are shown in Figure 5 (p. 54). 
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Figure 5. Average interest ratings for psychosocial delivery methods.  
 
 
The highest mean levels of interest were in face-to-face (M = 6.21, SD = 3.50) 
and personal effort (M = 6.13, SD = 2.30) methods of intervention. Eighty-three percent 
(n = 10) and 75% (n = 9) of the participants rated their interest as a five or higher in 
personal effort and face-to-face methods of intervention, respectively.  Participants’ mean 
interest ratings for Internet (M = 4.79, SD = 2.74), support group (M = 4.77, SD = 3.39), 
and telephone (M = 5.38, SD = 3.15) methods of intervention were about the middle of 
the 1-10 scale.  Two-thirds (n = 8) of the participants rated the Internet and telephone at 
an interest level of five or higher.  It should be noted that one participant could not rate 
his level of interest in a support group method of intervention. 
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current usage, and limited use or no interest.  One-quarter of the participants (n = 3) 
explained that the reliability of information from the Internet influenced their ratings, 
typically inciting caution in those participants (e.g., “Sometimes I don’t know how 
reliable the source is.”).  Usually when explaining why the participant rated their interest 
in the Internet as a five or higher, participants (n = 4, 33.3%) perceived the Internet as a 
source of information (e.g., “Well, the Internet helps a lot. It gives you information.”).  
One participant (8.3%) indicated that currently using the Internet influenced the interest 
rating.  However, five participants (41.7%) indicated that not using the Internet or having 
no interest in using the Internet explained their low interest ratings.  Interviews from two 
of the participants provided no categories under the Internet theme. 
 
Face-to-Face 
Four categories emerged from the rationales provided for interest ratings given 
regarding face-to-face interventions: tailored and immediate information, nonverbal 
communication, trusted expert and professional support, and no interest.  Two 
participants (16.7%) indicated that having information that was specific (i.e., tailored to 
their case) and immediate from another individual was important to them (e.g., “The 
reasoning behind that is as you are seeing or talking about things, questions arise while 
you are talking. You want an answer and right then.”).  Three participants (25.0%) 
reported that viewing an individual’s nonverbal communication was important to them 
(e.g., “You can read a lot in the expression of a person.”) and also influenced one of their 
ratings to be higher than telephone-based interventions (e.g., “It was easier for me to read 
somebody by having one-on-one contact.”).  One-half (n = 6) of the study sample 
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indicated that receiving face-to-face support from an individual recognized as a trusted 
professional or expert was important to them (e.g., “I think I want to be one-on-one with 
a doctor.”).  Three participants (25.0%) reported having limited interest in receiving face-
to-face support.  Interviews from three participants contained no categories under the 
theme of face-to-face interventions. 
 
Support Group 
When participants were queried for their rationales for their interest ratings in a 
support group format for an intervention, seven categories emerged.  The categories 
included timing of joining a group (i.e., does it coincide with current need or future 
need), having previous experience in a support group, being in a group of individuals that 
share common experiences (e.g., specific cancer type), hearing positive and hopeful 
aspects of group members’ experiences, disliking hearing about stories from others in the 
group, desiring an expert panel (i.e., professionals or experts compose the group members 
to inform the patient), and no interest.  Out of those categories, participants (n = 5, 
41.7%) most frequently stated that having a group composed of members with similar 
experiences (e.g., having lung cancer) was important to them (e.g., “People with the same 
diagnosis can relate more to each other.”).  It was also stated that finding groups that 
shared a lung cancer diagnosis was difficult to find (e.g., “I was trying to find a support 
group, but all you can find is breast cancer.”).  Three participants (25.0%) reported that 
their interest in a support group depended upon whether they perceived that they needed 
it at that time, which might increase or decrease depending on the severity of their 
physical and emotional distress (e.g., “Maybe if it occurred again…if I had another 
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recurrence.  That might change my mind.  I don’t know.”).  One-quarter (n = 3) of the 
study sample also indicated that listening to positive and hopeful stories was an important 
component of a support group (e.g., “…hearing their stories…their positive stories.”).  
Two participants (16.7%) stated that previous experience with a support group influenced 
their interest level.  Two participants also stated that their low interest level was 
influenced the desire to not talk about experiences with cancer among other people (e.g., 
“I always shied away from them.  That may be because I don’t like speaking of things 
like that with others.”).  One participant (8.3%) stated that interest would be high 
dependent on whether the group was composed of a group of professionals who would 
inform the individual on what to do given the individual’s case (e.g., “If it was a group of 
doctors talking about it saying, ‘This is what we can do,’ that would be different.”).  
However, four participants indicated that they would not be interest in a support group 
format.  Interviews from two participants contained no categories under the theme of 
support group interest. 
 
Telephone 
Four categories emerged from rationales provided for relative interest levels in a 
telephone-based psychosocial intervention.  Categories included convenience of 
telephone use, previous experience in using a telephone-based support service, receipt of 
reliable support (e.g., from a professional), and no interest.  Three participants (25.0%) 
reported that previous use of a telephone-based service influenced their interest rating.  
Two participants (16.7%) stated that their high interest ratings were attributable to the 
convenience of a telephone-based service (e.g., “I could call a 24-hour nurse line.”).  Two 
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other participants indicated that having reliable support and information (e.g., from an 
expert) would influence their interest levels (e.g., “I could rely on the information that 
they give me.”).  Two participants indicated that they were not interested in telephone-
based service.  Interviews from four participants contained no text in the four categories 
to explain rationales for telephone use. 
 
Personal Effort 
Four categories emerged from analyzing the rationales of interest levels regarding 
personal effort in meeting needs: perceiving themselves as information gatherers, 
desiring some guidance in seeking help or information, feeling little motivation without 
external help, and using the Internet.  Five participants (41.7%) stated that they saw 
themselves as information gatherers and recalled events in which they gathered 
informational resources relevant to them (e.g., “I try to get information from the people I 
know…from all the doctors.”).  Four participants (33.3%) specified that they utilized the 
Internet as a tool to meet their information-seeking needs (e.g., “I use the computer a lot 
for my health.”).  One participant (8.3%) explained that his low rating was due to needing 
guidance in meeting personal needs (e.g., “I would like to know where to find reliable 
research.”).  Another participant indicated that his low interest was due to limited 
motivation without the external support.  Interviews from two participants contained no 
categories to explain interest levels in implementing personal efforts to meet needs. 
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CHAPTER FOUR 
DISCUSSION 
 
Lung Cancer Patients’ Most Pertinent Psychosocial Needs 
Although about half (41.7%) of the lung cancer patients in this study initially 
reported no current psychosocial needs, all patients indicated some psychosocial need 
that was pertinent to them.  These findings from this study suggest that the most pertinent 
psychosocial needs for lung cancer patients are more information regarding lung cancer 
and its treatment, fatigue, and anxiety about future medical results or about negative 
effects from cancer (each reported by over half of the participants).  This matches 
moderately well with the findings from Sanders et al. (2010), whose quantitative findings 
suggested that lack of energy or tiredness (i.e., fatigue; 75%), uncertainty about the future 
(64%), and work around the home (64%) were the most endorsed unmet supportive care 
needs.  In the same study, although information about diagnosis and treatment was not 
the most reported unmet need, more lung cancer patients indicated interest in services 
offered free of charge that were geared towards meeting that need (i.e., information; 
61%) compared to any other type of service.  Also, Devitt et al. (2010) found that the 
most desired content for a support group was information related to lung cancer and its 
treatment (96-78% for specific categories of information).  The rates of categories of 
reported psychosocial needs appeared to match well with Sanders et al. (2010).  For 
example, Sanders and colleagues reported a slightly lower (66%) rate of unmet need in 
the health system and informational domain, a similar rate of lung cancer patients who 
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met the CES-D cutoff for depression (37.4%), and a similar rate of anxiety (about 49%) 
when compared to the lung cancer patients interviewed in this study. 
 
Barriers that Hinder Lung Cancer Patients’ Engagement in 
Psychosocial Interventions 
The barriers reported most frequently by lung cancer patients in this study were 
time-related and travel-related issues, followed by barriers of limited motivation or 
necessity as well as limited finances.  The travel barrier has been reported in the findings 
of Devitt et al. (2010).  Besides not wanting to participate in a support group (most often 
reported), Devitt and colleagues found that the barriers most often expressed by lung 
cancer patients were difficulty with transportation and parking (38%), not wanting to 
travel (37%), and not wanting to talk about lung cancer (37%).  
 
Lung Cancer Patients’ Interest in Specific Modes of Intervention 
Delivery 
The findings from this study indicated that lung cancer patients were most 
interested in interventions delivered via face-to-face methods.  They also showed a 
similar level of interest in meeting their psychosocial needs for information via personal 
effort (i.e., limited external support).  However, more lung cancer patients stated that 
their interest level was a five or greater for meeting their needs through personal effort 
(83.3%) compared to their interest ratings given for a face-to-face format (75%). 
 
 
 61 
Internet-based Format 
Internet-based psychosocial interventions directed toward lung cancer patients 
may be more likely to be utilized if it is clear that it is from a reliable source (e.g., cite 
journal articles for informational interventions).  Patients may also show more interest if 
Internet-based interventions advertise the breadth and depth of information that is 
provided by the website. 
 
Telephone-based Format 
Psychosocial interventions delivered through the telephone should focus on 
emphasizing its convenience to lung cancer patients, especially when time-related and 
travel-related barriers are apparent.  Also, the credibility of the individual (e.g., the 
credentials) speaking to the lung cancer patient should be made clear. 
 
Support Group Format 
According to the findings of Devitt et al. (2010) and this study, it is important for 
lung cancer patients to be in a support group with others who are also diagnosed with 
lung cancer.  Given that some participants in the this study indicated that the timing (i.e., 
whether I believe that I am currently in need of a support group now) of when the support 
group is offered could affect their interest, it may be useful for lung cancer patients to be 
clearly informed of what needs a given support group can fill. 
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Limitations 
This study had several limitations.  Since the interviews were carried out in a 
cross-sectional design, lung cancer patients’ experiences could be captured only at one 
point in time and may not reflect what their perspectives were before and after the 
interviews.  Also, the study suffered from a low sample size (n = 12), which is lower than 
the sample size recommended (n = 20) by Creswell et al. (2007).  Further, the study 
sample is less often diagnosed at later stages of cancer progression (i.e., stage III and 
stage IV) and less ethnically diverse when compared to national estimates of regional 
(22%) and distant (56%) spread of cancer from the lungs and bronchus and estimates of 
the ethnic distribution of the age-adjusted lung cancer incidence (60.55 for white and 
69.16 for black ethnic groups per 100,000 individuals in the United States in 2008; 
SEER).  The low sample size and lack of similarity to the national population of lung 
cancer patients possibly bias the results from this study and limits the study’s external 
validity. 
 
Implications for Psychosocial Intervention Development for Lung 
Cancer Patients 
Psychosocial interventions can address lung cancer patients’ most pertinent needs 
if information regarding lung cancer and its treatments, fatigue-related support, and 
services that address patients’ anxiety about future medical exam results or cancer 
recurrence are provided in a face-to-face format or via resources accessible by the 
patients (e.g., the Internet).  Lung cancer patients should be offered interventions at times 
and locations that facilitate their engagement. Also, the intervention should be efficiently 
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delivered such that as little of the patient’s time is taken.  If available, they should be 
made aware of transportation services that can deliver them to the site of the intervention 
and financial reimbursements for which they qualify to address travel-related and 
income-related barriers. Given that a lack of information about psychosocial 
interventions was a barrier for several patients in this study, it is important to be clear 
about what is offered and what involvement entails for a patient in any intervention.  
Considering the diversity of psychosocial needs presented by lung cancer patients in this 
study and across previous studies (e.g., Sanders et al., 2010 and Li & Girgis, 2006), any 
psychosocial intervention should begin with a subjective needs assessment of the target 
population (Green & Kreuter, 2000).  After determining their available resources, 
psychosocial intervention developers may then find how their capabilities can meet the 
needs of the target population. 
 
Implications for Future Research 
Future investigations regarding psychosocial interventions addressing lung cancer 
patients’ psychosocial needs, barriers to engage in psychosocial interventions, and 
preferred intervention channels, should be conducted with ethnically diverse samples that 
are stratified according to the national distribution of ethnic groups and cancer staging for 
lung cancer.  Also, a longitudinal replication of this study with a larger sample of lung 
cancer patients (n  20; Creswell et al., 2007) would result in good external validity and 
facilitate the generalizability of findings to the theoretical population of lung cancer 
patients.  Given that lung cancer patients have reported that their experience of stigma, 
shame, and blame affected their motivation to go to doctor’s appointments (Chapple et 
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al., 2004), it may also be informative for future research to specifically explore whether 
lung cancer patients’ experience of stigma, self-blame, and shame might affect their 
interest or motivation to attend a psychosocial intervention.  Although the results from 
this study found no barriers related to stigma, shame, or self-blame, it may be due to the 
low sample size (biased results) and the format of the interview (i.e., not specifically 
asking about self-blame, shame, or stigma).  Finally, it may be informative for future 
investigations to explore how lung cancer patients perceive barriers to engage in 
psychosocial interventions according to the mode of delivery. For example, patients may 
perceive a different set of barriers if asked about engagement in a face-to-face 
intervention versus an Internet-based intervention. 
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APPENDIX 
 
Telephone Script 
Hello, this is Kevin Criswell from Loma Linda University.  May I speak with 
(patient’s name)?  Hello (patient’s name).  I am calling on behalf of Dr. Jason Owen.  We 
received your completed questionnaire and I would like to thank you for taking the time 
to complete and return it.  After reviewing your responses, I noticed that you might be 
interested in participating in future research.  Did you receive the letter I sent you?   
(If patient responds “Yes,” then proceed with the telephone script.) 
(If patient responds “No,” then explain that a letter was sent containing a consent 
sheet as well as a letter, notifying that he/she will receive a call from a researcher within 
the next two weeks.  Then proceed with the telephone script.) 
I am making this call to ask you to take part in a telephone interview, which may 
take about 20 minutes.  It will involve questions about nonmedical needs you have, how 
you would like those needs to be met, and any difficulties you find in obtaining those 
needs.  The interview will be recorded and transcribed for use in our study.  To thank you 
for your time, you will be reimbursed with a $20 gift card to Target.  At the conclusion of 
the study, the recording and its transcription will be destroyed to protect your 
confidentiality.  Would you be willing to take part in this interview? 
(If patient responds “No,” then reply, “Thank you for your time.  Goodbye.”) 
(If patient responds “Yes,” then reply with the following script.) 
Thank you.  Is it okay if we begin the interview now or would you like to 
schedule a later time for the interview?   
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(If patient responds by saying that he/she would like to begin the interview now, 
then reply with the following script.) 
We will start in just a moment.  Please keep in mind that you may choose to end 
the interview at any time. (Skip to the Interview Schedule.) 
(If patient responds by saying that he/she would like schedule the interview at 
another time, then reply with the following script.) 
When would you like to schedule our interview? (Record the time that the 
participant and an investigator can mutually agree on.) Okay, I will be calling you back 
on [recite the agreed time to conduct the interview]. Thank you for your time.  Goodbye.  
 
Scheduled Interview Call 
Hello, this is Kevin Criswell from Loma Linda University.  May I speak with 
(patient’s name)?  Hello (patient’s name).  I called you a while ago to ask if you could 
take part in an interview about any nonmedical needs you have, how you would like 
those needs to be met, and any difficulties you find in obtaining those needs.  When we 
talked, you had mentioned that this time would work for taking part in this interview.  
Are you ready to begin the interview? 
(If patient responds by saying that he/she would like to begin the interview now, 
then reply with the following script.) 
We will start in just a moment.  Please keep in mind that you may choose to end 
the interview at any time. (Skip to the Interview Schedule.) 
(If patient responds by saying that he/she would like schedule the interview at 
another time, then reply with the following script.) 
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When would you like to schedule our interview? (Record the time that the 
participant and an investigator can mutually agree on.) Okay, I will be calling you back 
on [recite the agreed time to conduct the interview]. Thank you for your time.  Goodbye. 
(If patient responds by saying that he/she does not want to participate, then reply, 
“Okay.  Thank you for your time.  Goodbye.”) 
 
Interview Schedule 
(Begin recording the interview.)   
1.  Please think about how you are currently living with your cancer every day.  
When you think about it, what types of needs do you usually require help with? 
(Probe: Of those needs, which would you consider to be the most important to you?  
Why?  On a scale from one to ten, one being little to no interest and ten being extremely 
interested, how interested are you in receiving support for your most important need?  
Why?) 
2.  On a scale from one to ten, one being little to no interest and ten being extremely 
interested, what is your level of interest in the following ways of meeting your needs: 
 Internet ___ Why is it a (the number the patient indicated for Internet)? 
 Face-to-face ___ Why is it a (the number the patient indicated for Face-to-face)? 
 A group of others who have also been diagnosed with lung cancer ___   ___ Why is it 
a (the number the patient indicated for a lung cancer support group)? 
 Telephone ___ Why is it a (the number the patient indicated for Telephone)? 
 On your own (e.g., reading materials, website, etc.) ___ Why is it a (the number the 
patient indicated for personal research)? 
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3. Now, I am going to ask you about what you think might get in the way of seeking help 
for any of your needs.  Some of these roadblocks for seeking help can include personal, 
social, physical, financial, or other areas of life.  Please tell me specifically why you 
would find it difficult to seek help to get your needs met. 
(Probe: Of those difficulties, which do you consider most troublesome?  Why?) 
4. At the place where you receive or have received treatment for your cancer, have you 
been given information about any support services that you are eligible to receive?   
(Probe if any services are recalled: Can you recall what services are offered?  Of those 
services that you recall, which ones interest you the most?) 
5. Are there any other things that you would like to mention before we end the 
interview? 
(Stop recording the interview.) 
Thank you for your time.  Your responses will be kept confidential and will help 
us to develop more effective nonmedical services for lung cancer patients.  Also, you will 
receive your $20 reimbursement by mail.  Have a good day. 
(Hang up the phone.) 
